BioWorld Asia

Aug. 20, 2003

Chromosomal Breaks Could Hold Clues To Cancer Targets

Xenova Adding To Pipeline Via £8.5M KS Biomedix Acquisition

LONDON - Consolidation continues in the UK as Xenova Group plc announced an agreed-to £8.48 million (US$13.5 million) all-share takeover offer for KS Biomedix plc (KSB). (BioWorld International) Read More

Merck Drops Lead Molecule In Estrogen Program With Karo Bio

Codon Chair Says Company On Track Despite Turmoil At Top

BresaGen Moving Operations To U.S. For Better Biotech Climate

IsoTis Outlicenses Skin Product, Keeps Focus On Bone Programs

U.S., Others Formally Call For Panel On GMO Issue In Europe

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 24, 2024.

Illustration of neurons with Lewy bodies

Enhanced Cognition: Lewy body dementia phase II pumps stock

BioWorld

Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...

Experimental mRNA gene therapy suppresses preeclampsia in mice

BioWorld MedTech

A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...

Lab glassware and antibodies art concept

Probing bidirectional cancer-autoimmune link can yield new targets

BioWorld Science

Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...